Chang‐Ching Lin

Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity

Ariella B. Hanker, Benjamin P. Brown, Jens Meiler et al. · Cancer Cell · 2021 · 99 citations · Full text

Medicine, Genetics, Molecular Biology +15

Nuclear FGFR1 Regulates Gene Transcription and Promotes Antiestrogen Resistance in ER+ Breast Cancer

Alberto Servetto, Rahul K. Kollipara, Luigi Formisano et al. · Clinical Cancer Research · 2021 · 75 citations · Full text

Medicine, Cancer Biology, Oncology +17

Probing the interaction between the histone methyltransferase/deacetylase subunit RBBP4/7 and the transcription factor BCL11A in epigenetic complexes

Rebecca Reed Moody, Miao‐Chia Lo, Jennifer L. Meagher et al. · Journal of Biological Chemistry · 2017 · 70 citations · Full text

Medicine, Molecular Biology, Oncology +16

Herb-Drug Interaction of 50 Chinese Herbal Medicines on CYP3A4 Activity<i>in Vitro</i>and<i>in Vivo</i>

Li‐Heng Pao, Oliver Yoa‐Pu Hu, Hsien-Yuan Fan et al. · The American Journal of Chinese Medicine · 2012 · 63 citations

Medicine, Biochemistry, Pharmacology +17

Epigenetic Repression of STING by MYC Promotes Immune Evasion and Resistance to Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer

Kyung‐min Lee, Chang‐Ching Lin, Alberto Servetto et al. · Cancer Immunology Research · 2022 · 60 citations · Full text

Medicine, Cancer Biology, Oncology +17